News & Updates

Show Multimedia Only
How does IV edaravone fare for ALS in the real world?

How does IV edaravone fare for ALS in the real world?

10 May 2022
Trabectedin–durvalumab combo shows antitumour activity in refractory ovarian carcinoma

Trabectedin–durvalumab combo shows antitumour activity in refractory ovarian carcinoma

10 May 2022